midazolam has been researched along with palbociclib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hoffman, J; Loi, CM; Wang, D; Yu, Y | 1 |
1 trial(s) available for midazolam and palbociclib
Article | Year |
---|---|
Physiologically Based Pharmacokinetic Modeling of Palbociclib.
Topics: Administration, Intravenous; Administration, Oral; Area Under Curve; Biological Availability; Computer Simulation; Cross-Over Studies; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase 6; Cyclin-Dependent Kinase Inhibitor Proteins; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Enzyme Induction; Humans; Midazolam; Models, Biological; Piperazines; Pyridines | 2017 |